Limited Competition: NIA Genome Center for Alzheimer's Disease (U54 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Posted on:
Date limite d´inscription:
Expired
Type
Research/project funding
Reference Number
PAR-19-288
This Funding Opportunity Announcement (FOA) invites applications to continue the operations of the NIA Genome Center for Alzheimer's Disease (GCAD) to facilitate and support the Alzheimer's Disease Sequencing Project (ADSP) activities. GCAD will serve as the focal point for all phases of ADSP quality control checking, data harmonization, and meta-analysis. The FOA is intended to support a major component of the full range of analysis for the ADSP. The spectrum of the Center's activities comprises a multidisciplinary attack on Alzheimer's Disease (AD) and AD Related Dementias (ADRD) in keeping with NIA's programmatic needs. The Center will serve as a national resource for the specific purpose of identifying potential avenues for therapeutic approaches and prevention of the disease.
Categories: Health.
Categories: Health.
États-Unis